All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy

All-trans retinoic acid (ATRA) was used in a case of acute promyelocytic leukemia (APL) in late pregnancy. A very prompt maternal risk reduction was achieved with subsequent complete remission and spontaneous delivery of two live children in whom no fetal damage seems to have occurred.

Saved in:

Bibliographic Details
Published in:	Leukemia Vol. 8; no. 9; p. 1585
Main Authors:	Stentoft, J, Nielsen, J L, Hvidman, L E
Format:	Journal Article
Language:	English
Published:	England 01-09-1994
Subjects:	Adult Female Fibrinogen - metabolism Hemoglobins - metabolism Humans Leukemia, Promyelocytic, Acute - blood Leukemia, Promyelocytic, Acute - drug therapy Leukocyte Count Platelet Count Pregnancy Pregnancy Complications, Neoplastic - blood Pregnancy Complications, Neoplastic - drug therapy Pregnancy Outcome Pregnancy Trimester, Third Remission Induction Thrombin Time Tretinoin - therapeutic use
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	All-trans retinoic acid (ATRA) was used in a case of acute promyelocytic leukemia (APL) in late pregnancy. A very prompt maternal risk reduction was achieved with subsequent complete remission and spontaneous delivery of two live children in whom no fetal damage seems to have occurred.
ISSN:	0887-6924